Managing Director
China Renaissance Securities (US) Inc.
Debra Yu, MD is Managing Director and Head of Cross Border Healthcare Investment Banking at China Renaissance Securities (US), a global investment bank with offices in Beijing, Shanghai, Hong Kong and New York. She has 30 years of experience in the life sciences industry where she has been a VC investor, a company executive and a strategic advisor to companies worldwide. Previously she was Managing Director of Labrador Advisors, where she advised clients in multiple life sciences industry sub-segments including biopharma, specialty pharma, medtech, research instrumentation and diagnostics and executed numerous successful business development transactions in the US and in China. Earlier, Debra helped architect and co-led the Pfizer venture capital group and was General Partner of Delphi Ventures and Managing Director of Bay City Capital. She also served as acting CEO of Molecular Applications Group and managed its strategic sale. Her interest in China led her to serve as VP Strategy for WuxiApptec, a leading Chinese CRO. Debra began her industry training at Morgan Stanley in the venture capital group. She later joined McKinsey & Co., in New York and London as a core member of the Healthcare practice leadership team. She received a BA with high honors in Molecular Biology from Princeton University earned an MD from Harvard Medical School. She currently serves on the board of Bayhelix, a China-U.S. cross-border life sciences leadership organization. Debra is also a Governor of the Asian American Alumni Association of Princeton University.

Emerging Opportunities in Global Markets

11:45 AM–5:00 PM Jun 4, 2018 (US - Eastern)

Room 253ABC, Level 2

Katherine AndersenHead of Healthcare Corporate Finance and East/Central Life Science atSilicon Valley Bank Mr. Michael ChanSenior Vice President atHong Kong Exchanges and Clearing Limited (HKEX) Helen ChenManaging Director, Head of L.E.K. China and Asia Life Sciences atL.E.K. Consulting Tony ChenPartner atJones Day Shanghei Joseph DamondExecutive Vice President, International Affairs atBiotechnology Innovation Organization Yuan-Hua DingExecutive Director and Head of External Science & Innovation atPfizer Inc. Monica H.Director, International Affairs atBiotechnology Innovation Organization Edward HuChief Financial Officer and Chief Investment Officers atWuXi AppTec Kewen JinManaging Partner atSerica Partners Alex JungPartner/Managing DIrector atEY-Parthenon Wei LiFounding Partner at6 Dimensions Capital Micah MackisonSenior VP for Corporate Development and Strategy atAssembly Biosciences Wendy PanBoard of Directors atBayHelix Donghui QinDirector of Innovation atFerring Pharmaceuticals Greg ScottFounder and Chairman atChinaBIO Group Victor ShiChairman atBayHelix Alan TurleyDeputy Assistant Secretary for China atU.S. Department of Commerce Jonathan WangSenior VP and Head of Business Development atZai Lab Lijun WuChief Scientific Officer and Senior VP R&D, Fosun Pharma USA atShanghai Henlius Biotech Haishan XiongSenior Vice President for Business Development atFountain Medical Development GE YanfengDirector-General of the Research Department of Social Development atDevelopment Research Center of the State Council (DRC) Debra YuManaging Director atChina Renaissance Securities (US) Inc.